---
$id: https://graph.org.ai/products/commodity/51111748
$type: Product
source: UNSPSC
code: "51111748"
title: "Ladirubicin"
class: "51111700"
classTitle: "Antineoplastic antibiotics"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Ladirubicin

**UNSPSC Code**: 51111748
**Class**: [Antineoplastic antibiotics](Antineoplastic antibiotics.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anthracycline antibiotic with the molecular formula C29H31NO11S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier U395ERO49H. The term LADIRUBICIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 15 no. 1, 2001, list 45. ). Most nations schedule ladirubicin under HS 29419000 and SITC 54139. As of Q4 2014, LADIRUBICIN remains the US FDA Preferred Term for this commodity. Ladirubicin bears US NLM identifiers UMLS ID C2827222 and NCI Concept Code C83861. SMILES: CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=CC=CC=C5C4=O)O)(C(=O)C)O)N6CC6)OS(=O)(=O)C.

